Company Filing History:
Years Active: 2021
Title: The Innovations of Jianwu Wang
Introduction
Jianwu Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on enhancing the efficacy of therapeutic drugs through innovative approaches.
Latest Patents
Wang holds a patent for an afucosylated monoclonal antibody. This invention provides a human IgG antibody with an afucosylated sugar chain structure at a heavy-chain sugar chain binding site. The monoclonal antibody has applications in the preparation of antineoplastic drugs. Compared to fucosylated monoclonal antibodies, Wang's afucosylated monoclonal antibody demonstrates higher biological activity both in vitro and in vivo. This advancement can lead to the development of more effective therapeutic monoclonal antibody drugs.
Career Highlights
Throughout his career, Jianwu Wang has worked with various biotechnology companies. Notably, he has been associated with Beijing Gefucure Biotechnology Limited Company and Wuxi Kingenew Biotechnology Limited Company. His experience in these organizations has contributed to his expertise in the field.
Collaborations
Wang has collaborated with several professionals in his field, including Bo Tang and Ran Zhang. These collaborations have likely enriched his research and development efforts.
Conclusion
Jianwu Wang's innovative work in the field of monoclonal antibodies showcases his commitment to advancing biotechnology. His contributions have the potential to significantly impact therapeutic drug development.